Kaitai Capital is a Hangzhou based venture capital management company investing in innovative technology companies in multiple industries world wide. Kaitai focuses its investments on biotechnology, medicine, healthcare services, agriculture tech, consumer business, outdoor sports, financial services, artificial intelligence, and digital technology. Founded in 2009, it has physical presence in San Jose, United States, and Hangzhou and Beijing in China. As of 2019, the company has invested in 28 companies with two successful exits.
Timeline
Funded Companies
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
Amphivena Therapeutics is a San Francisco-based company.
Totient is a San Francisco-based company founded by Kevin Britz.
People
Chuangen zhou
Partner
Datao cheng
Partner
Fangcai xu
Partner
Hao xｕ
Partner
Huadi dong
Brand manager
Huan liu
Associate
Lei chen
Partner
Lei liu
Vice president
Liangchang Fang
Partner
Linfu WANG
Partner
Xiaotong qin
Associate
Xiaying huang
Associate
Yin chen
Vice president
Yonghong XU
Founding partner
Yuanbo li
Vice president
Zhongbao li
Associate
Further reading
Documentaries, videos and podcasts
Companies
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Niroj Manandhar
Software Engineer - 2
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 3
Carla Faraguna
Golden People and Operations. - 4
Henry Ogolla
Passionate about reading and writing. - 5
Kat Guzman
Human Interface Developer obsessed with neuroscience, books and human performance. - 6
Mevludin Mešanović
Bachelor of Electrical Engineering